ASTH

SEC source: 0001104659-20-012602 · tm207161d1_4a.xml · nonDerivative · entry 1

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 916,446

F1 · kind: This Amendment reports the rescission on February 5, 2020 ab initio of the entire grant on November 27, 2019 of restricted shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · acquired: This Amendment reports the rescission on February 5, 2020 ab initio of the entire grant on November 27, 2019 of restricted shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

SEC source: 0001104659-20-023834 · tm209648-8_4.xml · derivative · entry 1

Kitayama Mitchell W · CIK 0001333154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,050

Underlying: Common Stock · 3,550 shares

Expires 2024-11-25

F1 · derivative.exercise_price: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · kind: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · shares: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · derivative.exercise_date: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · derivative.expiration_date: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

SEC source: 0001104659-20-023833 · tm209648d7_4.xml · derivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,578

Underlying: Common Stock · 1,578 shares

Expires 2024-11-25

F1 · derivative.exercise_price: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · kind: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · shares: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · derivative.exercise_date: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · derivative.expiration_date: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

SEC source: 0001104659-20-023832 · tm209648d6_4.xml · derivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,050

Underlying: Common Stock · 3,550 shares

Expires 2024-11-25

F1 · derivative.exercise_price: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · kind: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · shares: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · derivative.exercise_date: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · derivative.expiration_date: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

SEC source: 0001104659-20-023830 · tm209648-5_4.xml · derivative · entry 1

Fawcett Mark · CIK 0001664134 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,050

Underlying: Common Stock · 3,550 shares

Expires 2024-11-25

F1 · derivative.exercise_price: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · kind: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · shares: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · derivative.exercise_date: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · derivative.expiration_date: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

SEC source: 0001104659-20-023826 · tm209648-3_4a.xml · derivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,000

Underlying: Common Stock · 900 shares

Expires 2024-11-25

F1 · derivative.exercise_price: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · kind: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · shares: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · derivative.exercise_date: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

SEC source: 0001104659-20-023827 · tm209648d4_4a.xml · derivative · entry 1

Fawcett Mark · CIK 0001664134 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,500

Underlying: Common Stock · 2,048 shares

Expires 2024-11-25

F1 · derivative.exercise_price: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · kind: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · shares: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · derivative.exercise_date: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

SEC source: 0001104659-20-023825 · tm209648-2_4a.xml · derivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,500

Underlying: Common Stock · 2,048 shares

Expires 2024-11-25

F1 · derivative.exercise_price: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · kind: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · shares: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · derivative.exercise_date: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

SEC source: 0001104659-20-023823 · tm209648d1_4a.xml · derivative · entry 1

Kitayama Mitchell W · CIK 0001333154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,500

Underlying: Common Stock · 2,048 shares

Expires 2024-11-25

F1 · derivative.exercise_price: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · kind: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · shares: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · derivative.exercise_date: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

SEC source: 0001104659-20-046383 · tm2015807d5_4a.xml · derivative · entry 1

Kitayama Mitchell W · CIK 0001333154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,909

Underlying: Common Stock · 3,409 shares

Expires 2024-11-25

F1 · derivative.exercise_price: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · kind: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · shares: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · derivative.exercise_date: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · derivative.expiration_date: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · derivative.underlying_shares: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · balance_after: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

SEC source: 0001104659-20-046381 · tm2015807d4_4a.xml · derivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,909

Underlying: Common Stock · 3,409 shares

Expires 2024-11-25

F1 · derivative.exercise_price: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · kind: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · shares: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · derivative.exercise_date: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · derivative.expiration_date: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · derivative.underlying_shares: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · balance_after: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

SEC source: 0001104659-20-046379 · tm2015807d3_4a.xml · derivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,515

Underlying: Common Stock · 1,515 shares

Expires 2024-11-25

F1 · derivative.exercise_price: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 63 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · kind: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 63 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · shares: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 63 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · derivative.exercise_date: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 63 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · derivative.expiration_date: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 63 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · derivative.underlying_shares: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 63 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · balance_after: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 63 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

SEC source: 0001104659-20-046377 · tm2015807d2_4a.xml · derivative · entry 1

Fawcett Mark · CIK 0001664134 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,909

Underlying: Common Stock · 3,409 shares

Expires 2024-11-25

F1 · derivative.exercise_price: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · kind: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · shares: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · derivative.exercise_date: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · derivative.expiration_date: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · derivative.underlying_shares: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · balance_after: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

SEC source: 0001250853-20-000059 · primary_doc.xml · nonDerivative · entry 1

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 966,296

F1 · kind: The original Form 4, filed on February 7, 2020, is being amended to reflect the correct amount of securities beneficially owned following the reported transaction.

SEC source: 0001104659-20-004433 · tm203591d1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,307,214

F1 · shares: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on December 12, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $18.15 to $18.50. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-20-004079 · tm203453-1_4.xml · nonDerivative · entry 2

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,302,916

F1 · shares: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on December 12, 2019.

F3 · price: This transaction was executed in multiple trades at prices ranging from $17.52 to $17.98. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-20-004079 · tm203453-1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,295,786

F1 · shares: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on December 12, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $17.35 to $17.44. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-076942 · tm1928380d4_4.xml · derivative · entry 2

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,046

Underlying: Common Stock · 28,046 shares

Expires 2024-12-30

F2 · derivative.exercise_price: Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on December 30, 2020), one-third after year two (on December 30, 2021), and the final one-third after year three (on December 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on December 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date the grant was approved by the Company.

F2 · kind: Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on December 30, 2020), one-third after year two (on December 30, 2021), and the final one-third after year three (on December 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on December 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date the grant was approved by the Company.

F2 · derivative.exercise_date: Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on December 30, 2020), one-third after year two (on December 30, 2021), and the final one-third after year three (on December 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on December 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date the grant was approved by the Company.

SEC source: 0001104659-19-076942 · tm1928380d4_4.xml · nonDerivative · entry 1

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,343

F1 · kind: Restricted shares of Common Stock of Apollo Medical Holdings, Inc. (the "Company") granted under the Company's 2015 Equity Incentive Plan, subject to vesting one-third after year one (on December 30, 2020), one-third after year two (on December 30, 2021), and the final one-third after year three (on December 30, 2022).

SEC source: 0001104659-19-076941 · tm1928380d3_4.xml · derivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,046

Underlying: Common Stock · 28,046 shares

Expires 2024-12-30

F2 · derivative.exercise_price: Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on December 30, 2020), one-third after year two (on December 30, 2021), and the final one-third after year three (on December 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on December 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date the grant was approved by the Company.

F2 · kind: Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on December 30, 2020), one-third after year two (on December 30, 2021), and the final one-third after year three (on December 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on December 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date the grant was approved by the Company.

F2 · derivative.exercise_date: Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on December 30, 2020), one-third after year two (on December 30, 2021), and the final one-third after year three (on December 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on December 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date the grant was approved by the Company.

SEC source: 0001104659-19-076941 · tm1928380d3_4.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,343

F1 · kind: Restricted shares of Common Stock of Apollo Medical Holdings, Inc. (the "Company") granted under the Company's 2015 Equity Incentive Plan, subject to vesting one-third after year one (on December 30, 2020), one-third after year two (on December 30, 2021), and the final one-third after year three (on December 30, 2022).

SEC source: 0001104659-19-076929 · tm1928380d2_4a.xml · derivative · entry 2

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 39,189 shares

Expires 2024-09-30

F2 · derivative.exercise_price: This Amendment reports the rescission on December 27, 2019 ab initio of the entire grant on September 30, 2019 of stock options to purchase shares of the Company's common stock under the Company's 2015 Equity Incentive Plan.

F2 · kind: This Amendment reports the rescission on December 27, 2019 ab initio of the entire grant on September 30, 2019 of stock options to purchase shares of the Company's common stock under the Company's 2015 Equity Incentive Plan.

F2 · shares: This Amendment reports the rescission on December 27, 2019 ab initio of the entire grant on September 30, 2019 of stock options to purchase shares of the Company's common stock under the Company's 2015 Equity Incentive Plan.

F2 · derivative.exercise_date: This Amendment reports the rescission on December 27, 2019 ab initio of the entire grant on September 30, 2019 of stock options to purchase shares of the Company's common stock under the Company's 2015 Equity Incentive Plan.

SEC source: 0001104659-19-076929 · tm1928380d2_4a.xml · nonDerivative · entry 1

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This Amendment reports the rescission on December 27, 2019 ab initio of the entire grant on September 30, 2019 of restricted shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · acquired: This Amendment reports the rescission on December 27, 2019 ab initio of the entire grant on September 30, 2019 of restricted shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

SEC source: 0001104659-19-076928 · tm1928380d1_4a.xml · derivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 39,189 shares

Expires 2024-09-30

F2 · derivative.exercise_price: This Amendment reports the rescission on December 27, 2019 ab initio of the entire grant on September 30, 2019 of stock options to purchase shares of the Company's common stock under the Company's 2015 Equity Incentive Plan.

F2 · kind: This Amendment reports the rescission on December 27, 2019 ab initio of the entire grant on September 30, 2019 of stock options to purchase shares of the Company's common stock under the Company's 2015 Equity Incentive Plan.

F2 · shares: This Amendment reports the rescission on December 27, 2019 ab initio of the entire grant on September 30, 2019 of stock options to purchase shares of the Company's common stock under the Company's 2015 Equity Incentive Plan.

F2 · derivative.exercise_date: This Amendment reports the rescission on December 27, 2019 ab initio of the entire grant on September 30, 2019 of stock options to purchase shares of the Company's common stock under the Company's 2015 Equity Incentive Plan.

SEC source: 0001104659-19-076928 · tm1928380d1_4a.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This Amendment reports the rescission on December 27, 2019 ab initio of the entire grant on September 30, 2019 of restricted shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · acquired: This Amendment reports the rescission on December 27, 2019 ab initio of the entire grant on September 30, 2019 of restricted shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

SEC source: 0001104659-19-073982 · tm1926597d1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,290,317

F1 · price: This transaction was executed in multiple trades at prices ranging from $18.24 to $18.60. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-073515 · tm1926483-1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,275,317

F1 · price: This transaction was executed in multiple trades at prices ranging from $18.20 to $18.75. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-073160 · tm1926361d1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,260,317

F1 · price: This transaction was executed in multiple trades at prices ranging from $18.88 to $18.99. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-072681 · tm1925270-1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,245,317

F1 · price: This transaction was executed in multiple trades at prices ranging from $17.90 to $18.54. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-072308 · tm1925162-1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,209,599

F1 · price: This transaction was executed in multiple trades at prices ranging from $17.76 to $18.18. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-071987 · tm1925084d1_4.xml · nonDerivative · entry 2

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,185,926

F3 · price: This transaction was executed in multiple trades at prices ranging from $16.99 to $17.72. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-071542 · tm1924968d1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,064,939

F1 · price: This transaction was executed in multiple trades at prices ranging from $16.29 to $17.23. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-071105 · tm1924836d1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,041,477

F1 · price: This transaction was executed in multiple trades at prices ranging from $16.81 to $18.54. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-071991 · tm1925095d1_4.xml · nonDerivative · entry 2

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Allied Physicians of California, A Professional Medical Corporation

Disclosed balance after: 17,158,389

F1 · date: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · date: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

F1 · kind: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · kind: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

F1 · shares: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · shares: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

F4 · ownership.nature: The securities acquired represent the Holdback Shares that were released as part of the Merger to Allied Physicians of California, A Professional Medical Corporation of which Reporting Person is an officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.

SEC source: 0001104659-19-071991 · tm1925095d1_4.xml · nonDerivative · entry 1

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 966,301

F1 · date: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · date: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

F1 · kind: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · kind: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

F1 · shares: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · shares: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

F3 · balance_after: Excludes the Reporting Person's indirect ownership of common stock of the Issuer as a shareholder of Allied Physicians of California, A Professional Medical Corporation.

SEC source: 0001104659-19-071987 · tm1925084d1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,158,389

F1 · date: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · date: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

F1 · kind: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · kind: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

F1 · shares: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · shares: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

SEC source: 0001104659-19-071975 · tm1925089d1_4.xml · nonDerivative · entry 2

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Allied Physicians of California, A Professional Medical Corporation

Disclosed balance after: 17,158,389

F1 · date: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · date: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

F1 · kind: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · kind: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

F1 · shares: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · shares: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

F5 · ownership.nature: The securities acquired represent the Holdback Shares that were released as part of the Merger to Allied Physicians of California, A Professional Medical Corporation of which Reporting Person is a director, officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.

SEC source: 0001104659-19-071975 · tm1925089d1_4.xml · nonDerivative · entry 1

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Kenneth T. and Simone S. Sim Family Trust dated November 7, 2013

Disclosed balance after: 1,824,439

F1 · date: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · date: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

F1 · kind: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · kind: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

F1 · shares: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · shares: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

F3 · balance_after: Excludes the Reporting Person's indirect ownership of common stock of the Issuer as a shareholder of Allied Physicians of California, A Professional Medical Corporation.

F4 · ownership.nature: The securities acquired are Holdback Shares owned directly by the Kenneth T. and Simone S. Sim Family Trust dated November 7, 2013. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose.

SEC source: 0001104659-19-071984 · tm1925087d1_4.xml · nonDerivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Allied Physicians of California, A Professional Medical Corporation

Disclosed balance after: 17,158,389

F1 · date: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · date: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

F1 · kind: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · kind: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

F1 · shares: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · shares: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

F5 · ownership.nature: The securities acquired represent the Holdback Shares that were released as part of the Merger to Allied Physicians of California, A Professional Medical Corporation of which Reporting Person is a director, officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.

SEC source: 0001104659-19-071984 · tm1925087d1_4.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by The Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 1,830,497

F1 · date: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · date: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

F1 · kind: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · kind: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

F1 · shares: On December 8, 2017, a merger transaction between Apollo Medical Holdings, Inc. (the "Issuer") and Network Medical Management, Inc. ("NMM") was consummated (the "Merger"). As previously disclosed in the Issuer's SEC filings, at the closing of the Merger, 10% of the total number of shares of the Issuer's common stock issuable to pre-Merger NMM shareholders was held back to secure indemnification rights of the Issuer and its affiliates (the "Holdback Shares"), which Holdback Shares were to be released to such pre-Merger NMM shareholders 50% on the first, and 50% on the second anniversaries of the closing of the Merger if no indemnification claims are made by such dates.

F2 · shares: No indemnification claim was made before December 8, 2019 and, accordingly, the second half of the Holdback Shares was automatically released for issuance on that date. The number of acquired securities reported in this statement represent the Reporting Person's pro rata portion of the released Holdback Shares. Accordingly, the Reporting Person is deemed to be the beneficial owner of those shares as of December 8, 2019.

F3 · balance_after: Excludes the Reporting Person's indirect ownership of common stock of the Issuer as a shareholder of Allied Physicians of California, A Professional Medical Corporation.

F4 · ownership.nature: The securities acquired are Holdback Shares owned directly by The Thomas and Jeanette Lam 2002 Family Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose.

SEC source: 0001104659-19-070742 · tm1924733d1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,002,877

F1 · price: This transaction was executed in multiple trades at prices ranging from $18.78 to $19.10. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-070314 · tm1924653-1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,970,514

F1 · price: This transaction was executed in multiple trades at prices ranging from $18.50 to $18.75. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-069998 · tm1924524d1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,956,919

F1 · price: This transaction was executed in multiple trades at prices ranging from $18.20 to $18.49. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-070571 · tm1924708d1_4.xml · nonDerivative · entry 1

Eng Michael F. · CIK 0001725261 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,890

F1 · price: This transaction was executed in multiple trades at prices ranging from $18.48 to $18.49. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-069656 · tm1924467-1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,938,380

F1 · price: This transaction was executed in multiple trades at prices ranging from $17.90 to $18.50. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-069143 · tm1924310d1_4.xml · nonDerivative · entry 2

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,918,380

F2 · price: This transaction was executed in multiple trades at prices ranging from $17.72 to $18.11. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-069143 · tm1924310d1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,899,778

F1 · price: This transaction was executed in multiple trades at prices ranging from $18.30 to $18.60. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-068353 · tm1924073-1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,893,278

F1 · price: This transaction was executed in multiple trades at prices ranging from $18.20 to $18.30. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-069173 · tm1924375-3_4.xml · nonDerivative · entry 1

Chin Eric · CIK 0001751197 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,722

F1 · kind: Restricted shares of Apollo Medical Holdings, Inc.'s (the "Company") Common Stock granted under the Company's 2015 Equity Incentive Plan, subject to vesting one-third on March 31, 2020, one-third on March 31, 2021, and the final one-third on March 31, 2022.

SEC source: 0001104659-19-069172 · tm1924375-2_4.xml · nonDerivative · entry 1

Ang Hing · CIK 0001725087 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,267

F1 · kind: Restricted shares of Apollo Medical Holdings, Inc.'s (the "Company") Common Stock granted under the Company's 2015 Equity Incentive Plan, subject to vesting one-third on March 31, 2020, one-third on March 31, 2021, and the final one-third on March 31, 2022.